[Federal Register: June 24, 2005 (Volume 70, Number 121)]
[Notices]
[Page 36642]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr24jn05-85]
[[Page 36642]]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Medicare & Medicaid Services
[CMS-5033-N5]
Medicare Program; Meeting of the Advisory Board on the
Demonstration of a Bundled Case-Mix Adjusted Payment System for End-
Stage Renal Disease Services--July 14 Through July 15, 2005
AGENCY: Centers for Medicare & Medicaid Services (CMS), HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: This notice announces the third public meeting of the Advisory
Board on the Demonstration of a Bundled Case-Mix Adjusted Payment
System for End-Stage Renal Disease (ESRD) Services. Notice of this
meeting is required by the Federal Advisory Committee Act (5 U.S.C.
App. 2, section 10(a)(1) and (a)(2)). The Advisory Board will provide
advice and recommendations with respect to the establishment and
operation of the demonstration mandated by section 623(e) of the
Medicare Prescription Drug, Improvement, and Modernization Act of 2003.
DATES: The meeting is on Thursday, July 14, 2005, from 9 a.m. to 5
p.m., eastern standard time and Friday, July 15, 2005, from 9 a.m. to 3
p.m. eastern standard time.
Special Accomodations: Persons attending the meeting, who are
hearing or visually impaired, or have a condition that requires special
assistance or accommodations, are asked to notify Pamela Morrow by July
7, 2005, by e-mail at ESRDAdvisoryBoard@cms.hhs.gov or by telephone at
(410) 786-2461.
ADDRESSES: The meeting will be held at the Marriott Hotel--BWI Airport,
1743 West Nursery Rd., Baltimore, MD 21240. Attendance is limited to
the space available, so seating will be on a first come, first served
basis.
Web site: Up-to-date information on this meeting is located at
http://www.cms.hhs.gov/faca/esrd.
Hotline: Up-to-date information on this meeting is located on the
CMS Advisory Committee Hotline at 1 (877) 449-5659 (toll free) or in
the Baltimore area at (410) 786-9379.
FOR FURTHER INFORMATION CONTACT: Pamela Morrow by e-mail at
ESRDAdvisoryBoard@cms.hhs.gov or telephone at (410) 786-2461.
SUPPLEMENTARY INFORMATION: On June 2, 2004, we published a Federal
Register notice requesting nominations for individuals to serve on the
Advisory Board on the Demonstration of a Bundled Case-Mix Adjusted
Payment System for End-Stage Renal Disease (ESRD) Services. The June 2,
2004, notice also announced the establishment of the Advisory Board and
the signing by the Secretary on May 11, 2004, of the charter
establishing the Advisory Board. On January 28, 2005, we published a
Federal Register notice announcing the appointment of eleven
individuals to serve as members of the Advisory Board on the
Demonstration of a Bundled Case-Mix Adjusted Payment System for ESRD
Services, including one individual to serve as co-chairperson, and one
additional co-chairperson, who is employed by CMS. The first public
meeting of the Advisory Board was held on February 16, 2005. The second
public meeting of the Advisory Board was held on May 24, 2005. This
notice announces the third public meeting of this Advisory Board.
I. Topics of the Advisory Board Meeting
The Advisory Board on the Demonstration of a Bundled Case-Mix
Adjusted Payment System for ESRD Services will study and make
recommendations on the following issues:
The drugs, biologicals, and clinical laboratory tests to
be bundled into the demonstration payment rates.
The method and approach to be used for the patient
characteristics to be included in the fully case-mix adjusted
demonstration payment system.
The manner in which payment for bundled services provided
by non-demonstration providers should be handled for beneficiaries
participating in the demonstration.
The feasibility of providing financial incentives and
penalties to organizations operating under the demonstration that meet
or fail to meet applicable quality standards.
The specific quality standards to be used.
The feasibility of using disease management techniques to
improve quality and patient satisfaction and reduce costs of care for
the beneficiaries participating in the demonstration.
The selection criteria for demonstration organizations.
II. Procedure and Agenda of the Advisory Board Meeting
This meeting is open to the public. The Advisory Board will hear
background presentations from CMS. The Advisory Board will then
deliberate openly on the general topic and will make recommendations on
specific topics for future meetings. The Advisory Board will also allow
at least a 30-minute open public session. Interested parties may speak
or ask questions during the public comment period. Comments may be
limited by the time available. Written questions should be submitted by
July 7, 2005, to ESRDAdvisoryBoard@cms.hhs.gov. Parties may also submit
written comments following the meeting to the contact listed under the
FOR FURTHER INFORMATION CONTACT section of this notice.
Authority: 5 U.S.C. App. 2, section 10(a).
(Catalog of Federal Domestic Assistance Program No. 93.774,
Medicare--Supplementary Medical Insurance Program)
Dated: June 16, 2005.
Mark B. McClellan,
Administrator, Centers for Medicare & Medicaid Services.
[FR Doc. 05-12523 Filed 6-23-05; 8:45 am]
BILLING CODE 4120-01-P